Concepedia
Statistics
Publications
6
Citations
164
H-Index
Active since
2015
Affiliations
The University of Tokyo(Current)
Tokyo University of Science
Koichiro Shoji is an author at The University of Tokyo specializing in oncogenic viruses, oncology, and molecular oncology.
Publications per year
2015–2020
Measles virus selectively blind to signaling lymphocyte activity molecule has oncolytic efficacy against nectin‐4‐expressing pancreatic cancer cells
Mutsumi Awano, Tomoko Fujiyuki, Koichiro Shoji et al. · Cancer Science · 2016 · 41 citations · Full text
Medicine, Cancer Biology, Oncology +17
Recombinant SLAMblind Measles Virus Is a Promising Candidate for Nectin-4-Positive Triple Negative Breast Cancer Therapy
Tomoko Fujiyuki, Yosuke Amagai, Koichiro Shoji et al. · Molecular Therapy — Oncolytics · 2020 · 31 citations · Full text
Medicine, Oncology, Pharmacology +12
Oncolytic Activity of a Recombinant Measles Virus, Blind to Signaling Lymphocyte Activation Molecule, Against Colorectal Cancer Cells
Yosuke Amagai, Tomoko Fujiyuki, Misako Yoneda et al. · Scientific Reports · 2016 · 28 citations · Full text
Medicine, Oncology, Pharmacology +16
A measles virus selectively blind to signaling lymphocytic activation molecule shows anti-tumor activity against lung cancer cells
Tomoko Fujiyuki, Misako Yoneda, Yosuke Amagai et al. · Oncotarget · 2015 · 27 citations · Full text
Life Sciences, Cancer Biology, Oncology +17
Development of new therapy for canine mammary cancer with recombinant measles virus
Koichiro Shoji, Misako Yoneda, Tomoko Fujiyuki et al. · Molecular Therapy — Oncolytics · 2016 · 24 citations · Full text
Life Sciences, Oncology, Veterinary Oncology +17
1–5 of 6